Terumo Gains FDA 510(k) for Surgery Monitoring Tech

Terumo Cardiovascular recently revealed that their next-generation CDI OneView monitoring system has received FDA 510(k) approval.

throughout cardiopulmonary bypass surgery, Terumo’s CDI systems show client metrics to promote circulatory safety and enhance results for patients.

Terumo stated that the latest system development aimed to offer the greatest amount of variability and versatility in terms of how the parameters might be prioritised and displayed. Simultaneously, it was imperative to guarantee the system maintained its provision of crucial data that physicians depend on.

Terumo Cardiovascular CEO stated “The world’s leading cardiac centers have trusted CDI Systems for over 30 years. With the launch of the new CDI OneView System, Terumo Cardiovascular continues to bring value and enhanced patient care to healthcare providers and critically ill cardiac patients,”

They continued “The CDI OneView System technology is the latest extension of Terumo’s commitment to delivering data-focused solutions to the perfusion community.”